Enovis Corp Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount
Enovis Corp (ENOV) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount of $5.35 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationNondeductibleExpense · last filed 2026-02-26
- Enovis Corp effective income tax rate reconciliation, nondeductible expense, amount for the quarter ending 2019-12-31 was -$15.99M.
- Enovis Corp effective income tax rate reconciliation, nondeductible expense, amount for the quarter ending 2012-03-30 was $42.90M.
- Enovis Corp effective income tax rate reconciliation, nondeductible expense, amount for fiscal 2025 was $5.35M, a 2.84% decline from fiscal 2024.
- Enovis Corp effective income tax rate reconciliation, nondeductible expense, amount for fiscal 2024 was $5.50M, a 5.16% increase from fiscal 2023.
- Enovis Corp effective income tax rate reconciliation, nondeductible expense, amount for fiscal 2023 was $5.23M, a 41.95% decline from fiscal 2022.
- Enovis Corp effective income tax rate reconciliation, nondeductible expense, amount for fiscal 2022 was $9.01M, a 251.80% increase from fiscal 2021.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount 3 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount 9 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount 12 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount 12 month as first filed |
|---|---|---|---|---|
| 2025-12-31 | $5.35M 10-K · filed 2026-02-26 | |||
| 2024-12-31 | $5.50M 10-K · filed 2026-02-26 | |||
| 2023-12-31 | $5.23M 10-K · filed 2026-02-26 | |||
| 2022-12-31 | $9.01M 10-K · filed 2025-02-26 | |||
| 2021-12-31 | $2.56M 10-K · filed 2024-02-22 | $3.02M 10-K · filed 2022-02-22 | ||
| 2020-12-31 | $4.45M 10-K · filed 2023-03-01 | $6.62M 10-K · filed 2021-02-18 | ||
| 2019-12-31 | -$15.99M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | $714.00K 10-K · filed 2022-02-22 | ||
| 2019-09-27 | $16.70M 10-Q · filed 2020-10-29 | |||
| 2018-12-31 | $1.07M 10-K · filed 2021-02-18 | |||
| 2012-03-30 | $42.90M 10-Q · filed 2013-04-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B | |
| NutriBand Inc. (NTRB) | United States | $0.109B | |
| LAKELAND INDUSTRIES INC (LAKE) | United States | $0.104B | -4.21 |
| Safe Pro Group Inc. (SPAI) | United States | $0.090B | |
| MYOMO, INC. (MYO) | United States | $0.065B | -2.85 |